华西口腔医学杂志

• 基础研究 • 上一篇    下一篇

多药耐药基因在口腔癌组织中的表达与分析研究

张杰,张建国,赵福运   

  1. 100081 北京大学口腔医学院
  • 收稿日期:2002-04-25 修回日期:2002-04-25 出版日期:2002-04-20 发布日期:2002-04-20
  • 基金资助:
    本课题为国家自然科学基金资助项目(编号39270724)

Expression of mdr1 in Oral Squamous Cell Carcinoma

Zhang Jie, Zhang Jianguo, Zhao Fuyun   

  1. The SchoolofStomatology,PekingUniversity
  • Received:2002-04-25 Revised:2002-04-25 Online:2002-04-20 Published:2002-04-20

摘要:

目的:研究多药耐药基因mdr1在口腔癌中的表达。方法:26例未接受任何药物化疗的口腔癌患者标本, Tca8113,Tca8113PV100和Tca8113PV200细胞系(分别耐药100 nmol和200 nmol),提取总RNA,以pchp-1作探针进行斑点杂交,根据标准条计算出每个样本的mdr1拷贝数。结果:26例口腔癌mdr1拷贝数范围为每微克013@105~ 5@105总mRNA。其中9例为不耐药,14例为中等耐药,3例高度耐药,耐药表达为65%,与肿瘤大小及病理分级无关。结论:口腔癌表达mdr1较高,临床要注意选择化疗方案。

关键词: 多药耐药, 口腔癌, 基因

Abstract:

Objective:The expression of mdr1 is associated with chemotherapeutic efficacy of cancer, some patientswith oral cancer are resistant to chemotherapy, the authors therefore investigated the mRNA expression level of mdr1 in oral squamous carcinoma. Methods:Totally 26 sampleswere investigated in this study, and the total RNAof oral squamous cell carcinoma each sample were extracted and hybridized with probe pchp-1 .The level of mdr1 were compared with the cell line Tca8113, Tca8113P100 and Tca8113P200, whichwere sensitive, resistant to VCR100 nmol and 200 nmol respectively.Results:The results showed that in the 26 patients, the mdr1 level ranged from0.3@105to 5@105. Among the 26 patients, 9 were drug-sensitive; 14 were lowdrug-re- sistant; and the other 3 were highly drug-resistant. The rate of drug resistance was 65%. The expression of mdr1 was not related with the pathologic differentiation and TNM classification.Conclusion:The multi-drug resistance of the malignant tumor to chemo- therapy is the important factor of unsatisfied effect of chemotherapy, and this paper systemically studied on the mdr1 expression of the oral squamous cell carcinoma, and the relation with pathologic differentiation and TNM classification. The result is important for choosing the chemotherapeutic regime for patients.

Key words: oral carcinoma, multi-drug resistance, gene